IBA to acquire ORA Group.

IBA, a company specialising in particle accelerator technology, agreed to acquire ORA Group, a company operating in the radiochemistry sector, known for its fully automated PET radiopharmaceutical synthesizers. Financial terms were not disclosed. This acquisition emphasizes IBA’s long-term commitment to the fast-developing and promising field of nuclear medicine. It reinforces IBA’s position at the forefront of innovation in precision oncology enabling for better diagnostic and more personalized patient therapy.